International Collaborations Necsa actively engages with Rosatom, CNNC, and Sibanye-Stillwater to advance nuclear medicine and workforce development, signaling demand for partner-enabled R&D, radiopharmaceutical development, and technology transfer opportunities.

Nuclear Medicine Focus The development of rhodium-derived radioactive isotopes and cancer treatment technologies indicates a growing market for radiopharmaceutical development, manufacturing capacity, QA, regulatory strategy, and clinical trial support.

Safety and Compliance As a national mandate body covering Nuclear Safety, Technology, and Non-Proliferation, Necsa represents demand for safety instrumentation, regulatory compliance software, incident management, and training programs to align with policies.

Capacity Building Partnerships for workforce development and participation in science outreach show appetite for talent development, training programs, e-learning, and sim labs, signaling opportunities for outsourced training services and equipment.

Regional Growth The SA-centric operation with international collaborations positions Necsa as a gateway for regional nuclear technology adoption, isotope supply chains, and joint ventures, presenting opportunities for equipment sales, supply agreements, and co-development ventures.